Veterinary Medicines

Tylan 200 injectie, oplossing voor injectie voor rund, kalf en varken

Authorised
  • Tylosin
Download as PDF

Product identification

Medicine name:
Tylan 200 injectie, oplossing voor injectie voor rund, kalf en varken
Active substance:
  • Tylosin
Target species:
  • Cattle
  • Pig
  • Cattle (calf)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Tylosin
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        5
        day
      • Meat and offal
        28
        day
    • Pig
      • Meat and offal
        16
        day
    • Cattle (calf)
      • Meat and offal
        28
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10100
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 10/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."